GSK corruption investigation widens


Pharma giant GlaxoSmithKline (GSK) has responded to allegations made by the BBC’s Panorama programme concerning improper conduct by GSK’s sales staff in Poland.

The programme alleged that GSK staff bribed doctors to prescribe asthma drug Seretide (fluticasone propionate and salmeterol), under the pretence of paying them to give educational talks about asthma to patients.

GSK says it became aware of allegations in 2011. A combined internal and external investigation found a single employee at fault, who has been disciplined by the company.

This is the latest in a series of high profile allegations of misconduct against GSK, most notably in China. The company has emphasised its ‘zero tolerance’ approach to unethical or illegal behaviour. ‘We publicly disclose all cases of misconduct identified in the company. Last year there were 161 violations relating to breaches of our sales and marketing polices, resulting in 48 dismissals and 113 written warnings. These numbers are very similar to those reported by other companies in our sector,’ the company said in a statement.

The company stressed that it does not believe the problem is systemic, and that the company is making efforts to eliminate possible conflicts of interest in its dealings with doctors. ‘We are the first company to have committed to stopping payments to doctors to speak about our products, stopping payments to doctors to attend medical conferences and stopping pay for our sales reps being linked to individual sales targets.’


Related Content

GSK fined £300 million for China corruption

25 September 2014 Business

news image

Several top executives jailed or deported

GSK’s China troubles continue

6 August 2014 Business

news image

Analysts say stings will only drive corruption into less visible channels

Most Read

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines

Most Commented

UCLA spent $4.5 million on legal costs in Sangji case

20 October 2014 News and Analysis

news image

University defends spending in case brought against chemistry professor, highlighting $20 million investment in lab safety

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines